Katz BZ - Search Results

1

Predictive value of TP53 fluorescence in situ hybridization in cytogenetic subgroups of acute myeloid leukemia.

Tavor S, Rothman R, Golan T, Voskoboinik N, Katz BZ, Sarid N, Shomrat R, Orr-Urtreger A, Naparstek E. Tavor S, et al. Among authors: katz bz. Leuk Lymphoma. 2011 Apr;52(4):642-7. doi: 10.3109/10428194.2010.551571. Epub 2011 Feb 16. Leuk Lymphoma. 2011. PMID: 21323513

2

Leukomogenic factors downregulate heparanase expression in acute myeloid leukemia cells.

Eshel R, Ben-Zaken O, Vainas O, Nadir Y, Minucci S, Polliack A, Naparstek E, Vlodavsky I, Katz BZ. Eshel R, et al. Among authors: katz bz. Biochem Biophys Res Commun. 2005 Oct 7;335(4):1115-22. doi: 10.1016/j.bbrc.2005.08.004. Biochem Biophys Res Commun. 2005. PMID: 16112651

3

The generation and regulation of functional diversity of malignant plasma cells.

Nadav L, Katz BZ, Baron S, Cohen N, Naparstek E, Geiger B. Nadav L, et al. Among authors: katz bz. Cancer Res. 2006 Sep 1;66(17):8608-16. doi: 10.1158/0008-5472.CAN-06-1301. Cancer Res. 2006. PMID: 16951174

4

Discrepancies in quantitative assessment of bone marrow involvement in lymphoma: do they reflect specialized micro-environmental cellular niches and cell-stromal interactions?

Katz BZ, Polliack A. Katz BZ, et al. Leuk Lymphoma. 2006 Sep;47(9):1730-1. doi: 10.1080/10428190600881041. Leuk Lymphoma. 2006. PMID: 17064979 No abstract available.

5

Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.

Katz BZ, Muhl L, Zwang E, Ilan N, Herishanu Y, Deutsch V, Naparstek E, Vlodavsky I, Preissner KT. Katz BZ, et al. Thromb Haemost. 2007 Dec;98(6):1193-9. Thromb Haemost. 2007. PMID: 18064313

6

Tumorigenic potential and disease manifestations of malignant B-cell variants differing in their fibronectin adhesiveness.

Nadav L, Kalchenko V, Barak MM, Naparstek E, Geiger B, Katz BZ. Nadav L, et al. Among authors: katz bz. Exp Hematol. 2008 Nov;36(11):1524-34. doi: 10.1016/j.exphem.2008.05.009. Epub 2008 Aug 9. Exp Hematol. 2008. PMID: 18694619 Free PMC article.

7

Side populations--following the footprints of the elusive multiple myeloma stem cells?

Katz BZ. Katz BZ. Leuk Lymphoma. 2008 Sep;49(9):1657-8. doi: 10.1080/10428190802334443. Leuk Lymphoma. 2008. PMID: 18798098 Review. No abstract available.

8

Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.

Dezorella N, Pevsner-Fischer M, Deutsch V, Kay S, Baron S, Stern R, Tavor S, Nagler A, Naparstek E, Zipori D, Katz BZ. Dezorella N, et al. Among authors: katz bz. Exp Cell Res. 2009 Jul 1;315(11):1904-13. doi: 10.1016/j.yexcr.2009.03.016. Epub 2009 Mar 27. Exp Cell Res. 2009. PMID: 19328780

9

The stromal derived factor-1\CXCR4 axis--a legitimate therapeutic target in multiple myeloma?

Katz BZ, Tavor S. Katz BZ, et al. Leuk Lymphoma. 2009 Jul;50(7):1067-8. doi: 10.1080/10428190902991837. Leuk Lymphoma. 2009. PMID: 19557626 No abstract available.

10

Mimicking the haematopoietic niche microenvironment provides a novel strategy for expansion of haematopoietic and megakaryocyte-progenitor cells from cord blood.

Deutsch V, Hubel E, Kay S, Ohayon T, Katz BZ, Many A, Zander A, Naparstek E, Grisaru D. Deutsch V, et al. Among authors: katz bz. Br J Haematol. 2010 Apr;149(1):137-49. doi: 10.1111/j.1365-2141.2009.08041.x. Epub 2010 Jan 18. Br J Haematol. 2010. PMID: 20085580 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters